Exagen Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.95

+0.30 (+11.32%)

As of Mar 31, 3:11 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +1,626.1% upside

Low Target $37.48

Average Target $50.92

High Target $70.07

Current Price $2.95

Current
$2.95

Target
$50.92

$37.48 $50.92 avg $70.07

Scenario Analysis

Bear Case

$37.48

1,170.5%

Low target

Base Case

$50.92

+1,626.1%

Avg target

Bull Case

$70.07

+2,275.3%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$12.23

-75.9% from high

52-Week Low

$2.65

+11.3% from low

Target vs 52W High

$50.92

+316.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%